레인 테라퓨틱스RNTX 주가

[PRE 14A] PRE 14A — PRE 14A

♻️ 재탕[4] 내부자 거래 — 4

♻️ 재탕Rein Therapeutics announces closing of $57.5 million underwritten public offering

Rein Therapeutics Inc: Rein Therapeutics announces closing of $57.5 million underwritten public offering, including full exercise of over-allotment option...

Rein Therapeutics Announces Closing of $57.5 Million Underwritten Public Offering, Including Full Exercise of Over-Allotment Option

Total gross proceeds increased to $57.5 millionOffering consisted solely of common stockProceeds expected to fund Phase 2 trial of LTI-03 in IPF through completion and support operations into 2028 ...

Rein Therapeutics Q1 EPS $(0.19) Beats $(0.49) Estimate

Rein Therapeutics (NASDAQ:RNTX) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.49) by 61.22 percent. This is a 24 percent increase over losses of $(0.25) per share from

[10-Q] 분기 실적 — 10-Q

[4] 내부자 거래 — 4

♻️ 재탕[SCHEDULE 13G/A] SCHEDULE 13G/A

[SCHEDULE 13G] SCHEDULE 13G

[SCHEDULE 13G] SCHEDULE 13G